基本信息
views: 118
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Siu’s major research focus is in the area of new anticancer drug development, particularly with respect to phase I trials and head and neck malignancies. In addition to her active research in early phase clinical trials, she has been leading genomics initiatives and immuno-oncology trials at the Princess Margaret Cancer Centre.
Research Interests
Papers共 898 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Clinical cancer researchno. 6 (2024): 1121-1130
K. Harrington,H.R. Kim, S. Salas, M. Oliva,R. Metcalf, M. Bernsdorf, J.W. Kim, E. Cohen,L.L. Siu,D. Rischin,L. Licitra,J. Vermorken,
International Journal of Radiation Oncology*Biology*Physicsno. 5 (2024): e42
Jesus Fuentes-Antras,Mitchell J. Elliott, Philippe Echelard, Aaron Dou,Zachary Veitch,Philippe L. Bedard,Eitan Amir,Michelle B. Nadler,Nicholas Meti,Nancy Gregorio, Elizabeth Shah,Emily Van de Laar,
CANCER RESEARCHno. 6 (2024): 2429-2429
crossref(2024)
crossref(2024)
Cancer discoveryno. 6 (2024): 1048-1063
Mitchell J. Elliott,Jesús Fuentes-Antrás,Aaron Dou,Nancy Gregorio,Elizabeth Shah,Emily Van de Laar, Geethika Yalamanchili, Leylah M. Drusbosky,Eitan Amir,Michelle B. Nadler,Celeste Yu,Hal K. Berman,
Cancer Researchno. 6_Supplement (2024): 969-969
crossref(2024)
crossref(2024)
Load More
Author Statistics
#Papers: 906
#Citation: 32719
H-Index: 95
G-Index: 162
Sociability: 8
Diversity: 3
Activity: 226
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn